A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

December 31, 2006

Conditions
Chagas CardiomyopathyHeart FailureDilated Cardiomyopathy
Interventions
DRUG

RASi plus carvedilol

Patients were randomly assigned to 2 groups, with 1 group receiving renin-angiotensin system inhibitors (enalapril) plus carvedilol and the other receiving renin-angiotensin system inhibitors (enalapril) plus placebo

Trial Locations (1)

Unknown

Chagas Disease Outpatient Center of the Federal University of Minas Gerais, Belo Horizonte

All Listed Sponsors
lead

Federal University of Minas Gerais

OTHER

NCT01557140 - A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy | Biotech Hunter | Biotech Hunter